Diagnostic application of BAP1 immunohistochemistry to differentiate pleural mesothelioma from metastatic pleural tumours

Histopathology. 2017 Dec;71(6):1011-1014. doi: 10.1111/his.13321. Epub 2017 Oct 2.

Authors

Masayo Yoshimura¹, Yoshiaki Kinoshita¹, Makoto Hamasaki¹, Shinji Matsumoto¹, Tomoyuki Hida², Yoshinao Oda², Kazuki Nabeshima¹

Affiliations

¹ Department of Pathology, Fukuoka University School of Medicine and Hospital, Fukuoka, Japan.
² Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

PMID: 28746778
DOI: 10.1111/his.13321

No abstract available

Publication types

Letter

MeSH terms

Biomarkers, Tumor / analysis*
Carcinoma / diagnosis
Carcinoma / secondary
Diagnosis, Differential
Humans
Immunohistochemistry / methods
Lung Neoplasms / diagnosis*
Mesothelioma / diagnosis*
Mesothelioma, Malignant
Neoplasm Metastasis / diagnosis*
Pleural Neoplasms / diagnosis*
Tumor Suppressor Proteins / analysis*
Ubiquitin Thiolesterase / analysis*

Substances

BAP1 protein, human
Biomarkers, Tumor
Tumor Suppressor Proteins
Ubiquitin Thiolesterase